China Resources Pharmaceutical Group (HKSE:03320) Ending Cash Position : HK$26,962 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Ending Cash Position?

China Resources Pharmaceutical Group's Ending Cash Position for the quarter that ended in Dec. 2023 was HK$26,962 Mil.

China Resources Pharmaceutical Group's quarterly Ending Cash Position increased from Dec. 2022 (HK$17,001 Mil) to Jun. 2023 (HK$24,222 Mil) and increased from Jun. 2023 (HK$24,222 Mil) to Dec. 2023 (HK$26,962 Mil).

China Resources Pharmaceutical Group's annual Ending Cash Position declined from Dec. 2021 (HK$17,541 Mil) to Dec. 2022 (HK$17,001 Mil) but then increased from Dec. 2022 (HK$17,001 Mil) to Dec. 2023 (HK$26,962 Mil).

China Resources Pharmaceutical Group Ending Cash Position Historical Data

The historical data trend for China Resources Pharmaceutical Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Pharmaceutical Group Ending Cash Position Chart

China Resources Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

12,543.46

11,220.54

17,541.21

17,000.56

26,962.38

China Resources Pharmaceutical Group Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															17,541.21	18,466.64	17,000.56	24,222.19	26,962.38

China Resources Pharmaceutical Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

China Resources Pharmaceutical Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	16651.39	+	10310.992
	=	26,962

China Resources Pharmaceutical Group's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	23624.014	+	3338.368
	=	26,962

China Resources Pharmaceutical Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Pharmaceutical Group (HKSE:03320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (HKSE:03320) » Definitions » Ending Cash Position

Traded in Other Exchanges

640:Germany

Address

26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG

Website

https://www.crpharm.com

CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. We estimate the company's operating income is approximately 53% distribution, 46% manufacturing, and less than 1% retail pharmacies.

Executives

Bei Jing Guo You Zi Ben Yun Ying Guan Li You Xian Gong Si

2201 Interest of corporation controlled by you

China Resources Pharmaceutical Group (HKSE:03320) Headlines

No Headlines